BiotechTV - News cover image

From Basel: TOLREMO Therapeutics is working on cancer resistance - the company believes is targeting CBP/p300 just stared phase 1 data at World Lung

BiotechTV - News

00:00

Combining TT125-802 With Osimertinib

Stefanie Fluckiger-Mangual outlines plans to test TT125-802 with osimertinib in EGFR-mutant lung cancer for deeper, longer responses.

Play episode from 06:22
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app